CLOs on the Move

Cargo

www.thecargoagency.com

 
We think Small Business is huge. And we think theyve been under-valued and under-developed as a marketing segment by big brands for far too long. Were Cargo, the authority on marketing and advertising to Small Business. We help a wide range of brands in a wide range of industries engage and influence the decision makers of the millions of Small Businesses that exist today. How? By using laser-guided creative, technology, and strategy to effectively build awareness and loyalty for the brands we work with. Brands who are looking to communicate with this very unique, very passionate target group. To explore our ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Forest Financial Group Inc

Forest Financial Group Inc is a Lake Bluff, IL-based company in the Business Services sector.

State of Nevada

Coordinates: 39°N 117°W / 39°N 117°W / 39; -117 Nevada is a state in the Western United States.

Hands On Recycling

Hands On Recycling is a Saint Petersburg, FL-based company in the Business Services sector.

240 Logistics - For the cannabis supply chain

Skye Bioscience Inc.

Skye Bioscience Inc. is a clinical-stage biotechnology company based in San Diego, California. The company focuses on developing innovative therapeutics for metabolic diseases, particularly obesity, by modulating the endocannabinoid system. Skye Bioscience is advancing its lead product, Nimacimab, a monoclonal antibody that targets peripheral CB1 receptors. This treatment aims to provide effective weight loss solutions while minimizing neuropsychiatric side effects associated with previous therapies. Nimacimab is currently in a Phase 2 trial, evaluating its efficacy in weight loss and metabolic health. The company is also exploring combination therapies to enhance treatment outcomes. Skye Bioscience positions Nimacimab as a potential alternative to existing GLP-1-based therapies, targeting patients who need sustainable weight loss with improved safety profiles. The obesity drug market presents significant opportunities, and Skye is actively participating in clinical trials and industry conferences to advance its mission in metabolic health.